Picture of Ashland logo

ASH — Ashland News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsBalancedLarge CapNeutral

Ashland misses Q4 revenue estimates

Overview

Ashland fiscal Q4 revenue down 8% yr/yr, missing analyst expectations

Adjusted EBITDA for fiscal Q4 beats analyst estimates, reflecting operational efficiency

Company received $103 mln tax refund, strengthening financial position

Outlook

Ashland expects fiscal 2026 sales between $1,835 mln and $1,905 mln

Company forecasts adjusted EBITDA of $400 mln to $430 mln for fiscal 2026

Ashland anticipates double-digit-plus growth in adjusted EPS excluding intangibles amortization

Result Drivers

PORTFOLIO OPTIMIZATION - Reduced sales by $38 mln due to divestitures and product line exits, impacting overall revenue

LIFE SCIENCES DEMAND - Stable demand in pharmaceuticals driven by innovation and high-value excipients

PERSONAL CARE GROWTH - Strong growth due to strategic investments and innovation across end markets

Key Details

MetricBeat/MissActualConsensus Estimate
Q4 RevenueMiss$478 mln$480.55 mln (7 Analysts)
Q4 EPS$0.71
Q4 Net Income$32 mln
Q4 Adjusted EBITDABeat$119 mln$118.26 mln (10 Analysts)
Q4 Free Cash Flow$52 mln
Press Release: ID:nGNX49W8yt For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Ashland

See all news